Molecular tumour pathology and tumour genetics
By unraveling the molecular pathways involved in tumorigenesis we aim to identify diagnostic markers and new therapeutic targets, such as protein kinases. The characterization of tumor tissues at genomic, transcriptomic and proteomic levels, combined -with analyses of various in vitro and in vivo model systems, are central themes. Ultimately, these molecular insights are expected to improve cancer diagnosis and to help develop personalized therapies for cancer patients.
A more extensive description of this research programme can be found here.
The subgroups participating in this research line are:
- Bone and soft tissue tumour pathology
- Hereditary Tumour Pathology
- Hereditary breast cancer
- Immunology and molecular genetics of gynecological cancers